12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

OMS103HP regulatory update

Omeros said that the European Medicines Agency (EMA) confirmed that an MAA for OMS103HP will be eligible for review under...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >